Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

[up] Up a level
Number of items: 16.

Burton, Jessica R., Halsby, Kate, de la Fuente, Graciela Sáinz, Pearson-Stuttard, Jonathan, Sloan, Rebecca, Porter, Thomas, John, Gareth, Warburton, Andrew, Selby, Jennifer, Povey, Gail, Chowdhury, Ruhe, Bale, Catherine, Davies, Mark, Clifton-Brown, Emma and Laing, Hamish 2025. Value-based healthcare in practice: IDEATE, a collaboration to design and test an outcomes-based agreement for a medicine in Wales. PharmacoEconomics 43 (2) , pp. 191-207. 10.1007/s40273-024-01445-0
file

Alcock, Amy, McVittie, Elizabeth, Nicholls, Zoe, Conti, Hector, Davies, Mark, Isaac, Rhian and Adams, Madeleine 2025. Incidental findings in surveillence of paediatric Li Fraumeni patients - A single centre experience. Rare 3 , 100067. 10.1016/j.rare.2025.100067
file

Abraham, Jean E., Pinilla, Karen, Dayimu, Alimu, Grybowicz, Louise, Demiris, Nikolaos, Harvey, Caron, Drewett, Lynsey M., Lucey, Rebecca, Fulton, Alexander, Roberts, Anne N., Worley, Joanna R., Chhabra, Anita, Qian, Wendi, Vallier, Anne-Laure, Hardy, Richard M., Chan, Steve, Hickish, Tamas, Tripathi, Devashish, Venkitaraman, Ramachandran, Persic, Mojca, Aslam, Shahzeena, Glassman, Daniel, Raj, Sanjay, Borley, Annabel, Braybrooke, Jeremy P., Sutherland, Stephanie, Staples, Emma, Scott, Lucy C., Davies, Mark, Palmer, Cheryl A., Moody, Margaret, Churn, Mark J., Newby, Jacqueline C., Mukesh, Mukesh B., Chakrabarti, Amitabha, Roylance, Rebecca R., Schouten, Philip C., Levitt, Nicola C., McAdam, Karen, Armstrong, Anne C., Copson, Ellen R., McMurtry, Emma, Tischkowitz, Marc, Provenzano, Elena and Earl, Helena M. 2024. The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer. Nature 629 , 1142–1148. 10.1038/s41586-024-07384-2
file

Munir, Asma, Holt, Simon, Huws, Anita Marie, Khan, Sohail, Davies, Mark, Khawaja, Saira and Sharaiha, Yousef 2023. A 10 year service evaluation of the survival of 439 patients with early oestrogen receptor positive breast cancer who underwent initial OncotypeDX ® testing to guide adjuvant chemotherapy decisions. Cancer Treatment and Research Communications 34 , 100671. 10.1016/j.ctarc.2022.100671
file

Farook, M. Rufaik, Croxford, Zack, Morgan, Steffan, Horlock, Anthony D., Holt, Amy K., Rees, April, Jenkins, Benjamin J., Tse, Carmen, Stanton, Emma, Davies, D. Mark, Thornton, Catherine A., Jones, Nicholas, Sheldon, I. Martin, Vincent, Emma E. and Cronin, James G. 2023. Loss of mitochondrial pyruvate carrier 1 supports proline-dependent proliferation and collagen biosynthesis in ovarian cancer. Molecular Metabolism 81 , 101900. 10.1016/j.molmet.2024.101900
file

Champion, Jesse D., Dodd, Kayleigh M., Lam, Hilaire C., Alzahrani, Mohammad A.M., Seifan, Sara, Rad, Ellie, Scourfield, David Oliver, Fishel, Melissa L., Calver, Brian L., Ager, Ann ORCID: https://orcid.org/0000-0002-5763-8908, Henske, Elizabeth P., Davies, D. Mark, Kelley, Mark R. and Tee, Andrew R. ORCID: https://orcid.org/0000-0002-5577-4631 2022. Drug inhibition of redox factor-1 restores hypoxia-driven changes in tuberous sclerosis complex 2 deficient cells. Cancers 14 (24) , 6195. 10.3390/cancers14246195
file

Mateo, Joaquin, Steuten, Lotte, Aftimos, Philippe, André, Fabrice, Davies, Mark, Garralda, Elena, Geissler, Jan, Husereau, Don, Martinez-Lopez, Iciar, Normanno, Nicola, Reis-Filho, Jorge S., Stefani, Stephen, Thomas, David M., Westphalen, C. Benedikt and Voest, Emile 2022. Delivering precision oncology to patients with cancer. Nature Medicine 28 (4) , 658–665. 10.1038/s41591-022-01717-2

Malorni, Luca, Tyekucheva, Svitlana, Hilbers, Florentine S., Ignatiadis, Michail, Neven, Patrick, Colleoni, Marco, Henry, Stéphanie, Ballestrero, Alberto, Bonetti, Andrea, Jerusalem, Guy, Papadimitriou, Konstantinos, Bernardo, Antonio, Seles, Elena, Duhoux, Francois P., MacPherson, Iain R., Thomson, Alastair, Davies, David Mark, Bergqvist, Mattias, Migliaccio, Ilenia, Gebhart, Géraldine, Zoppoli, Gabriele, Bliss, Judith M., Benelli, Matteo, McCartney, Amelia, Kammler, Roswitha, De Swert, Heidi, Ruepp, Barbara, Fumagalli, Debora, Maibach, Rudolf, Cameron, David, Loi, Sherene, Piccart, Martine and Regan, Meredith M. 2022. Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant. European Journal of Cancer 164 , pp. 39-51. 10.1016/j.ejca.2021.12.030

El Badri, Salma, Tahir, Bilal, Balachandran, Kirsty, Bezecny, Pavel, Britton, Fiona, Davies, D. Mark, Desouza, Karen, Dixon, Simon, Hills, Daniel, Moe, Maung, Pigott, Thomas, Proctor, Andrew, Shah, Yatri, Simcock, Richard, Stansfeld, Anna, Synowiec, Alicja, Theodoulou, Marianna, Verrill, Mark, Wadhawan, Anshu, Harper-Wynne, Catherine and Wilson, Caroline 2021. Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer: A real-world multicentre UK study. The Breast 60 , pp. 199-205. 10.1016/j.breast.2021.10.010
file

Holborow, Alexander, Coupe, Bryony, Davies, D. Mark and Zhou, Shangming 2019. Machine learning methods in predicting chemotherapy-induced neutropenia in oncology patients using clinical data. Clinical Medicine 19 (3) , s89-s90. 10.7861/clinmedicine.19-3s-s89
file

Johnson, Charlotte E. ORCID: https://orcid.org/0000-0003-1954-5142, Dunlop, Elaine A. ORCID: https://orcid.org/0000-0002-9209-7561, Seifan, Sara, McCann, Henry D., Hay, Trevor, Parfitt, Geraint J. ORCID: https://orcid.org/0000-0002-8704-7906, Jones, Ashley T., Giles, Peter J. ORCID: https://orcid.org/0000-0003-3143-6854, Shen, Ming H. ORCID: https://orcid.org/0000-0002-3891-7231, Sampson, Julian R. ORCID: https://orcid.org/0000-0002-2902-2348, Errington, Rachel J. ORCID: https://orcid.org/0000-0002-8016-4376, Davies, D. Mark and Tee, Andrew R. ORCID: https://orcid.org/0000-0002-5577-4631 2018. Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavir−bortezomib therapy to intensify endoplasmic reticulum stress-induced cell death. Oncogene 37 , pp. 5913-5925. 10.1038/s41388-018-0381-2
file

McCann, Henry, Johnson, Charlotte ORCID: https://orcid.org/0000-0003-1954-5142, Errington, Rachel ORCID: https://orcid.org/0000-0002-8016-4376, Davies, D. Mark, Dunlop, Elaine ORCID: https://orcid.org/0000-0002-9209-7561 and Tee, Andrew ORCID: https://orcid.org/0000-0002-5577-4631 2018. Energy stress-mediated cytotoxicity in tuberous sclerosis complex 2-deficient cells with nelfinavir and mefloquine treatment. Cancers 10 (10) , 375. 10.3390/cancers10100375
file

Murray, Alexandra J. and Davies, D. Mark 2013. The genetics of breast cancer. Surgery (Oxford) 31 (1) , pp. 1-3. 10.1016/j.mpsur.2012.10.019

Davies, David Mark and Sampson, Julian Roy ORCID: https://orcid.org/0000-0002-2902-2348 2010. Small-molecule signal-transduction inhibitors: targeted therapeutic agents for single-gene disorders. Journal of Medical Genetics 47 (3) , pp. 145-149. 10.1136/jmg.2008.064113

Davies, Mark 2009. Colorectal cancer and GI polyps: when to refer patients for genetic assessment. Gastrointestinal Nursing 7 (8) , pp. 36-42. 10.12968/gasn.2009.7.8.44748

Upadhyaya, Meena, Huson, Susan M., Davies, D. Mark, Thomas, Nicholas Stuart Tudor, Chuzhanova, Nadia, Giovannini, S., Evans, D. Gareth, Howard, E., Kerr, B., Griffiths, S., Consoli, Claudia, Side, L., Adams, D., Pierpont, M., Hachen, R., Barnicoat, A., Liu, H., Wallace, P., Van Biervliet, J. P., Stevenson, D., Viskochil, D., Baralle, D., Haan, E., Riccardi, V., Turnpenny, P., Lazaro, C. and Messiaen, Ludwine 2007. An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. The American Journal of Human Genetics 80 (1) , pp. 140-151. 10.1086/510781

This list was generated on Fri Apr 4 06:15:24 2025 BST.


Maintained by Cardiff University Information Services